HEADER NUCLEAR PROTEIN 23-MAY-05 2BSO TITLE DIMER MODEL OF MURINE BCL-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-52, 86-212; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: NO COORDINATES FOR 53-85 SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS BCL-2, APOPTOSIS, CANCER, NUCLEAR PROTEIN EXPDTA THEORETICAL MODEL AUTHOR V.S.MATHURA,K.V.SOMAN,T.K.VARMA,W.BRAUN REVDAT 1 24-MAY-05 2BSO 0 JRNL AUTH V.S.MATHURA,K.V.SOMAN,T.K.VARMA,W.BRAUN JRNL TITL A MULTIMERIC MODEL FOR MURINE ANTI-APOPTOTIC JRNL TITL 2 PROTEIN BCL-2 AND STRUCTURAL INSIGHTS FOR ITS JRNL TITL 3 REGULATION BY POST-TRANSLATIONAL MODIFICATION JRNL REF J.MOL.MODEL. V. 9 298 2003 JRNL REFN GE ESSN 1610-2940 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION ABOVE. REMARK 4 REMARK 4 2BSO COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY EBI ON 24-MAY-2005. REMARK 100 THE EBI ID CODE IS EBI-24196. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS MODEL WAS BUILT USING BCL-XL PDBCODE:1G5J AS REMARK 220 TEMPLATE REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 11 -81.87 59.78 REMARK 500 ASN B 11 -82.80 58.92 REMARK 500 ASN B 140 169.83 55.70 REMARK 500 LEU B 206 -49.24 82.24 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 86 PRO A 87 -147.93 REMARK 500 PRO A 87 PRO A 88 145.17 REMARK 500 PRO A 205 LEU A 206 84.40 REMARK 500 LEU A 206 PHE A 207 -128.79 REMARK 500 VAL B 86 PRO B 87 -148.12 REMARK 500 PRO B 87 PRO B 88 144.77 REMARK 500 SER B 164 PRO B 165 -146.14 DBREF 2BSO A 1 52 UNP P10417 BCL2_MOUSE 1 52 DBREF 2BSO A 86 212 UNP P10417 BCL2_MOUSE 86 212 DBREF 2BSO B 1 52 UNP P10417 BCL2_MOUSE 1 52 DBREF 2BSO B 86 212 UNP P10417 BCL2_MOUSE 86 212 SEQRES 1 A 179 MET ALA GLN ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 179 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 179 GLY TYR GLU TRP ASP ALA GLY ASP ALA ASP ALA ALA PRO SEQRES 4 A 179 LEU GLY ALA ALA PRO THR PRO GLY ILE PHE SER PHE GLN SEQRES 5 A 179 VAL PRO PRO CYS VAL HIS LEU THR LEU ARG ARG ALA GLY SEQRES 6 A 179 ASP ASP PHE SER ARG ARG TYR ARG ARG ASP PHE ALA GLU SEQRES 7 A 179 MET SER SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG SEQRES 8 A 179 GLY ARG PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP SEQRES 9 A 179 GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE SEQRES 10 A 179 GLY GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SEQRES 11 A 179 SER PRO LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU SEQRES 12 A 179 TYR LEU ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN SEQRES 13 A 179 GLY GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER SEQRES 14 A 179 MET ARG PRO LEU PHE ASP PHE SER TRP LEU SEQRES 1 B 179 MET ALA GLN ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 B 179 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 B 179 GLY TYR GLU TRP ASP ALA GLY ASP ALA ASP ALA ALA PRO SEQRES 4 B 179 LEU GLY ALA ALA PRO THR PRO GLY ILE PHE SER PHE GLN SEQRES 5 B 179 VAL PRO PRO CYS VAL HIS LEU THR LEU ARG ARG ALA GLY SEQRES 6 B 179 ASP ASP PHE SER ARG ARG TYR ARG ARG ASP PHE ALA GLU SEQRES 7 B 179 MET SER SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG SEQRES 8 B 179 GLY ARG PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP SEQRES 9 B 179 GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE SEQRES 10 B 179 GLY GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SEQRES 11 B 179 SER PRO LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU SEQRES 12 B 179 TYR LEU ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN SEQRES 13 B 179 GLY GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER SEQRES 14 B 179 MET ARG PRO LEU PHE ASP PHE SER TRP LEU HELIX 1 1 ASN A 11 GLY A 27 1 17 HELIX 2 2 GLU A 29 GLY A 33 5 5 HELIX 3 3 GLY A 47 PHE A 51 5 5 HELIX 4 4 PRO A 88 TYR A 105 1 18 HELIX 5 5 THR A 122 PHE A 135 1 14 HELIX 6 6 VAL A 139 ARG A 161 1 23 HELIX 7 7 SER A 164 HIS A 181 1 18 HELIX 8 8 HIS A 183 GLY A 190 1 8 HELIX 9 9 GLY A 190 TYR A 199 1 10 HELIX 10 10 LEU A 206 SER A 210 5 5 HELIX 11 11 ASN B 11 GLY B 27 1 17 HELIX 12 12 GLU B 29 GLY B 33 5 5 HELIX 13 13 GLY B 47 PHE B 51 5 5 HELIX 14 14 PRO B 88 ARG B 103 1 16 HELIX 15 15 ARG B 104 ARG B 106 5 3 HELIX 16 16 THR B 122 PHE B 135 1 14 HELIX 17 17 VAL B 139 MET B 154 1 16 HELIX 18 18 VAL B 156 ARG B 161 1 6 HELIX 19 19 SER B 164 HIS B 181 1 18 HELIX 20 20 HIS B 183 GLY B 190 1 8 HELIX 21 21 GLY B 190 TYR B 199 1 10 HELIX 22 22 PHE B 207 LEU B 212 1 6 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 58 0 0 22 0 0 0 6 0 0 0 28 END